We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

93 hedge funds and large institutions have $38.6M invested in Infinity Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 37 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

340% more call options, than puts

Call options by funds: $471K | Put options by funds: $107K

4% less funds holding

Funds holding: 97 → 93 (-4)

27% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 15

53% less capital invested

Capital invested by funds: $82.5M → $38.6M (-$43.8M)

54% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 37

Holders
93
Holders Change
-4
Holders Change %
-4.12%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
17
Reduced
37
Closed
15
Calls
$471K
Puts
$107K
Net Calls
+$364K
Net Calls Change
-$1.86M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$706K
2
GCP
GSA Capital Partners
United Kingdom
+$334K
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$315K
4
VOYA Investment Management
VOYA Investment Management
Georgia
+$182K
5
Morgan Stanley
Morgan Stanley
New York
+$176K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.73M
2
Millennium Management
Millennium Management
New York
-$818K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$555K
4
Marshall Wace
Marshall Wace
United Kingdom
-$339K
5
CC
Callan Capital
California
-$329K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCWM
101
Total Clarity Wealth Management
Illinois
– -$7K -3,000 Closed
EVM
102
Eaton Vance Management
Massachusetts
– -$2K -1,000 Closed
QC
103
Quent Capital
New York
– +$468 +392 New
GRP
104
Global Retirement Partners
California
– +$956 +800 New
1 2 3 4
5

INFI Hedge Fund Activity: Q1 2022 in Review

93 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q1 2022, worth a combined $38.6M — down 53% from $82.5M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of INFI and 11 opened new positions — a net loss of 4 holders — while 37 trimmed existing stakes and 17 added.

The largest buyer was Renaissance Technologies, adding an estimated $706K. The largest seller was Point72 Asset Management, exiting entirely with an estimated $1.73M sold.

  • 93 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q1 2022, down from 97 in Q4 2021.
  • Funds reported $38.6M of Infinity Pharmaceuticals, Inc. stock for Q1 2022, down 53% quarter-over-quarter.
  • 11 funds opened new Infinity Pharmaceuticals, Inc. positions in Q1 2022 and 15 closed out, a net change of -4 holders.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q1 2022 was Renaissance Technologies, an estimated $706K added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q1 2022 was Point72 Asset Management, an estimated $1.73M sold.

Based on aggregated 13F filings for Q1 2022.